Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06051955

Evaluation of an Oral Sodium Sulfate Solution for Patients With Prior Difficult or Incomplete Cleansing

Evaluation of an Oral Sodium Sulfate Solution for Patients With Prior Difficult or Incomplete Cleansing, a Progressive Case Series.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Lawrence Charles Hookey · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This case series aims to evaluate the effectiveness and tolerability of Oral Sulfate Solution (OSS) in patients who had previously experienced poor colonoscopy preparation.

Detailed description

This study aims to evaluate the effectiveness of Oral Sodium Sulfate (OSS) in patients who have had poor colon preparation in the past. The study includes patients who had issues during their previous colonoscopy, such as needing extensive washing, inadequate preparation, a recommendation for shorter surveillance intervals, or adequate preparation for larger polyps but not smaller lesions. Poor colon cleansing during a colonoscopy can lead to more prolonged procedures, lower polyp detection rates, and the need for repeat procedures with shorter surveillance intervals. OSS is a low-volume osmotic agent that causes diarrhea and colon cleansing by drawing water into the intestine. Health Canada and the FDA have approved it, and it is given in two 177ml bottles in a split dose. OSS is known for its good effect, ease of use, and tolerability, and it may be a better option than traditional cleansing agents. All participants will receive OSS and instructions for use before their next surveillance colonoscopy. The study will use questionnaires and patient diaries to assess the effectiveness of OSS and patient compliance and tolerability.

Conditions

Interventions

TypeNameDescription
OTHERoral sodium sulfateAll participants enrolled in this study will use Oral Sodium Sulfate as their bowel cleansing agent.

Timeline

Start date
2023-10-11
Primary completion
2024-05-30
Completion
2024-09-30
First posted
2023-09-25
Last updated
2024-04-03

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT06051955. Inclusion in this directory is not an endorsement.